Acesso livre
Acesso livre

Saúde Pública em Pediatria

Consenso | Ingestão de vitamina D e cálcio na população pediátrica geral.

23 Mar, 2022 | 11:48h

Vitamin D and calcium intakes in general pediatric populations: A French expert consensus paper – Archives de Pédiatrie


Tendências de tumores associados ao HPV, características demográficas e vacinação nos EUA, 2001-2017.

17 Mar, 2022 | 12:46h

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 – JAMA Network Open

Entrevista com o autor: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations

Conteúdos relacionados:

[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs


Diretriz da AAP | Vitamina K em recém-nascidos.

16 Mar, 2022 | 17:53h

Vitamin K and the Newborn Infant – Pediatrics

Comunicado de imprensa: Vitamin K policy addresses birth dose for term, preterm infants; parental concerns – American Academy of Pediatrics

Comentário: Newborns Should Receive Vitamin K Within Six Hours of Birth – HealthDay


Estudo randomizado | Em crianças com tuberculose não grave e suscetível a medicamentos, o tratamento por 4 meses é não inferior ao tratamento por 6 meses.

10 Mar, 2022 | 15:59h

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children – New England Journal of Medicine

Comunicado de imprensa: Treatment length reduced for children with tuberculosis – University College London

 

Comentário no Twitter

 


Relatório técnico AAP | Telemedicina: oportunidades para melhorar o acesso, a qualidade e o custo do cuidado pediátrico.

10 Mar, 2022 | 15:43h

Telehealth: Opportunities to Improve Access, Quality, and Cost in Pediatric Care – Pediatrics

Comunicado de imprensa: New AAP report reviews telehealth’s potential to transform pediatric care – AAP News


Extensão do alcance da gestão de antibióticos para pacientes pediátricos.

10 Mar, 2022 | 15:19h

Extending the Reach of Antimicrobial Stewardship to Pediatric Patients – Infectious Diseases and Therapy


Atualização do CDC e da AAP nos marcos de desenvolvimento em crianças para programa de vigilância.

8 Mar, 2022 | 18:26h

Comunicado de imprensa: CDC, AAP update developmental milestones for surveillance program – AAP News

Ver diretriz: Evidence-Informed Milestones for Developmental Surveillance Tools – Pediatrics

Comentários:

Revised Developmental Milestone Guidelines For Infants And Toddlers: Explained Here – Forbes

Much Awaited – Development Milestone Checklists Updated by CDC & AAP – Pediatric OnCall


Análise sistemática | Causas nacionais, regionais e globais de mortalidade em pacientes de 5 a 19 anos de idade de 2000 a 2019.

3 Mar, 2022 | 16:48h

National, regional, and global causes of mortality in 5–19-year-olds from 2000 to 2019: a systematic analysis – The Lancet Global Health

Comentário convidado: Child and adolescent deaths: a call for strengthening mortality surveillance systems – The Lancet Global Health


Miocardite após vacinação com BNT162b2 contra COVID-19 entre adolescentes em Hong Kong.

3 Mar, 2022 | 16:38h

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong – JAMA Pediatrics

Comentário: Study: Dosing change could reduce COVID-19 vaccine heart side effect in teens – UPI

Conteúdos relacionados:

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.


[Preprint] Estudo mostra efetividade significativamente reduzida da vacina da Pfizer em crianças de 5 a 11 anos após o surgimento da variante Ômicron.

1 Mar, 2022 | 15:36h

Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant – medRxiv

Comentários:

Pfizer Covid vaccine is less effective in kids 5 to 11, study finds – STAT

Pfizer Covid-19 vaccine effectiveness fell quickly for kids during Omicron surge but still offered some protection against severe disease – CNN

More mask mandates fall as poor COVID vaccine protection noted in young kids – CIDRAP


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.